Immediate and midterm complications of sclerotherapy: Report of a prospective multicenter registry of 12,173 sclerotherapy sessions

Dermatologic Surgery

Volumn 31, Issue 2, 2005, Pages 123-128

  Guex, Jean Jérôme ^a   Allaert, François André ^a   Gillet, Jean Luc ^a   Chleir, Franck ^a  

^a GPIP Groupe de Pathologie Infectieuse Pédiatrique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

POLIDOCANOL; SCLEROSING AGENT; TETRADECYL SULFATE SODIUM;

ANAPHYLACTIC SHOCK; ARTICLE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; FEMORAL VEIN; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; PARESTHESIA; PHLEBOLOGY; PRIORITY JOURNAL; SCLEROTHERAPY; SKIN NECROSIS; SUPERFICIAL THROMBOPHLEBITIS; SYNCOPE; VEIN THROMBOSIS; VISUAL DISORDER; VOMITING; CLINICAL PRACTICE; ENDOSCOPIC ECHOGRAPHY; FEMALE; FRANCE; INJECTION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; REGISTER; UTILIZATION REVIEW; VARICOSIS;

FEMALE; FRANCE; HUMANS; INJECTIONS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REGISTRIES; SCLEROSING SOLUTIONS; SCLEROTHERAPY; ULTRASONOGRAPHY, INTERVENTIONAL; VARICOSE VEINS;

EID: 15044354500     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042728-200502000-00001     Document Type: Article

References (12)

1. Hamel-Desnos C, Desnos P, Wollmann JC, et al. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 2003;29:1170-5.
2. Barrett JM, Allen B, Ockelford A, Goldman MP. Microfoam ultrasound-guided sclerotherapy of varicose veins in 100 legs. Dermatol Surg 2004;30:6-12.
3. Guex J-J. Ultrasound guided sclerotherapy for perforating veins. Hawaii Med J 2000;59:261.
4. Guex J-J. Indications for the sclerosing agent polidocanol. J Dermatol Surg Oncol 1993;19;959-61.
5. Kern P, Ramelet AA, Wutschert R, et al. Single-blind, randomized study comparing chromated glycerin, polidocanol solution and polidocanol foam for treatment of telangiectactic leg veins. Dermatol Surg 2004;30:367-72.
6. Conrad P, Malouf GM, Stacey MC. The Australian Polidocanol (Aethoxysklerol) Study. Results at 2 years. Dermatol Surg 1995;21: 334-6.
7. Conard J, Horellou MH, Elalamy I, Samama MM. Thromboses veineuses apres sclerotherapie; enquete clinico-biologique à propos de 42 observations. J Mal Vasc 1999;24(Suppl A):97.
8. Varcoe PF. Ultrasound guided sclerotherapy: efficacy, adverse effects and dosing. An international survey. Anz J Phleb 2004;7(2):17-24.
9. Sicot C. Rapport du conseil medical du Gamm, responsabilité 2004. Hors Série Mars:16.
10. Benigni JP, Ratinahirana H. Mousse de polidocanol et migraine a aura. Phlébologie 2003;56:289-91.
11. Guex J-J. Thrombotic complications of varicose veins. Dermatol Surg 1996;22:378-82.
12. Guex J-J. Sclerotherapy in venous disease. In: Davies AH, editor. Vascular surgery highlights 2003-04. London: Health Press; 2004. p. 38-44.